Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Urogenital Neoplasms × Androgen Antagonists × 1 year × Clear all

Sponsor

Conditions

Prostatic Neoplasms 50 Neoplasm Metastasis 4 Adenocarcinoma 3 Prostate Cancer Metastatic 2 Prostate CA 2 Metastatic Hormone-sensitive Prostate Cancer (mHSPC) 2 Triple Negative Breast Neoplasms 1 Stage IV Prostate Adenocarcinoma AJCC v7 1 Salivary Gland Neoplasms 1 Recurrence 1 Prostatic Diseases 1 Prostate Adenocarcinoma 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 PSA Level Greater Than 0.03 1 Oligometastatic Prostate Cancer 1 Neoplasms 1 Metastatic Hormone-sensitive Prostate Cancer 1 Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) 1 Metastatic Hormone-Sensitive Prostate Cance 1 Metastatic Hormone Sensitive Prostate Cancer 1 Metastatic Castration-resistant Prostate Cancer 1 Metastatic Castration Resistant Prostate Cancer 1 Metastatic Castrate-sensitive Prostate Cancer 1 Lymphatic Metastasis 1 Intraprostatic Prostate Cancer 1 Hormone Sensitive Prostate Cancer 1 Erectile Dysfunction 1 Breast Neoplasms 1 Adenocarcinoma of the Prostate 1

Interventions

pembrolizumab 3 Nivolumab 3 Ipilimumab 3 vedolizumab 2 fludarabine 2 darolutamide 2 cabozantinib 2 atezolizumab 2 aldesleukin 2 Specimen Handling 2 Riluzole 2 Prednisone 2 Magnetic Resonance Spectroscopy 2 LDP-02 2 Infliximab 2 Immunoglobulin G 2 Fecal Microbiota Transplantation 2 Disulfides 2 Cyclophosphamide 2 CTLA-4 Antigen 2 CT-P13 2 Biopsy 2 prednylidene 1 olaparib 1 gallium 68 PSMA-11 1 enfortumab vedotin 1 deltacortene 1 abiraterone 1 abemaciclib 1 Watchful Waiting 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡